Rang	Name	Position
1	Mr. Nikhil Lalwani	President, CEO & Director
2	Mr. Stephen P. Carey	Senior VP of Finance & CFO
3	Ms. Meredith W. Cook J.D.	Senior VP, General Counsel & Corporate Secretary
4	Mr. Christopher K. Mutz	Senior VP & Head of Rare Disease
5	Mr. Ori Gutwerg	Senior Vice President of Generics
6	Mr. Muthusamy Shanmugam MS R.Ph.	Head of R&D and COO of New Jersey Operations
7	Ms. Irina Rivkind Koffler	Vice President of Investor Relations
8	Ms. Elizabeth Powell J.D.	Chief Compliance Officer & Head of Legal of Rare Disease
9	Mr. Chad Gassert	Senior Vice President of Corporate Development & Strategy
10	Ms. Krista L. Davis	Senior VP & Chief Human Resources Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	11,96%	0,19 Mrd. USD
2	Soleus Capital Management, L.P.	3,78%	0,06 Mrd. USD
3	Vanguard Capital Management, LLC	3,58%	0,06 Mrd. USD
4	State Street Corp	3,36%	0,05 Mrd. USD
5	TANG CAPITAL MANAGEMENT LLC	3,08%	0,05 Mrd. USD
6	Dimensional Fund Advisors, Inc.	2,71%	0,04 Mrd. USD
7	American Century Companies Inc	2,50%	0,04 Mrd. USD
8	Arrowstreet Capital Limited Partnership	2,46%	0,04 Mrd. USD
9	Global Alpha Capital Management Ltd.	2,43%	0,04 Mrd. USD
10	Millennium Management LLC	2,21%	0,04 Mrd. USD
11	UBS Group AG	2,17%	0,04 Mrd. USD
12	Geode Capital Management, LLC	2,13%	0,03 Mrd. USD
13	Nuveen, LLC	1,75%	0,03 Mrd. USD
14	Vanguard Portfolio Management, LLC	1,64%	0,03 Mrd. USD
15	Ranger Investment Management LP	1,49%	0,02 Mrd. USD
16	Amvescap Plc.	1,41%	0,02 Mrd. USD
17	Deutsche Bank AG	1,39%	0,02 Mrd. USD
18	Kennedy Capital Management Inc	1,29%	0,02 Mrd. USD
19	Delaware Management Holdings Inc	1,25%	0,02 Mrd. USD
20	Aberdeen Group PLC	1,18%	0,02 Mrd. USD